Home › Stocks › IMNM

Immunome Inc. (IMNM): insider buying, hedge funds & Congress trades

Immunome Inc. (IMNM): 16 insider purchases in the last two years (1 opportunistic).

Insider buying

FiledInsiderSharesPriceValueType
Jun 9, 2026Bienaime Jean Jacques
Director
10,500$19.45$204.3Kno history
Mar 31, 2026Siegall Clay B
Director, Officer
25,450$19.67$500.6Kopportunistic
Mar 12, 2026Bienaime Jean Jacques
Director
2,000$21.84$43.7Kno history
Dec 30, 2025Siegall Clay B
Director, Officer
4,729$21.15$100.0Kno history
Dec 22, 2025Tsai Philip
Officer
10,000$20.49$204.9Kno history
Dec 22, 2025Siegall Clay B
Director, Officer
7,278$20.48$149.1Kno history
Dec 18, 2025Siegall Clay B
Director, Officer
46,511$21.50$1000.0Kno history
Jun 3, 2025Bienaime Jean Jacques
Director
5,000$9.38$46.9Kno history
Mar 26, 2025Siegall Clay B
Director, Officer
137,100$7.29$999.5Kno history
Mar 26, 2025Bienaime Jean Jacques
Director
7,800$7.78$60.7Kno history
Mar 25, 2025Tsai Philip
Officer
12,300$8.42$103.6Kno history
Mar 25, 2025Bienaime Jean Jacques
Director
7,000$8.21$57.5Kno history
Feb 3, 2025Siegall Clay B
Director, Officer
150,000$7.75$1.2Mno history
Nov 25, 2024Tsai Philip
Officer
21,000$9.43$198.0Kno history
Nov 25, 2024Lechleider Robert
Officer
15,805$9.48$149.8Kno history
Nov 25, 2024Siegall Clay B
Director, Officer
100,000$9.62$962.1Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for IMNM

Free account. Know when insiders, famous funds or Congress trade it.

Start free